The order directs the U.S. Food and Drug Administration to reduce the time it takes to approve drug manufacturing plants in the country, as well as to increase fees for inspections at foreign sites, according to the newspaper.
Pharmaceutical products have long been spared from trade wars due to potential harms, but Trump has repeatedly threatened tariffs on the sector in recent months.
According to the Washington Post report, the order directs the FDA to improve enforcement of active-ingredient source reporting by foreign producers and “consider publicly displaying a list of facilities that do not comply”.
So far, there is little clarity on the rates and timings of any sector-specific tariffs. But the industry could be in for a big hit if Trump goes ahead with his plans, since the U.S. imports more than $200 billion in prescription drugs.
Companies including Roche, Novartis, Eli Lilly and Johnson & Johnson have announced sizeable investments in U.S. manufacturing in recent weeks.
Hence then, the article about trump to sign order to encourage domestic drug manufacturing was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Trump to sign order to encourage domestic drug manufacturing )
Also on site :
- ‘Charlie’s Angel’ Star Gets Brutally Honest About Why the Show Never Won Any Major Awards: ‘They Put Us Down… We Were Barbie Dolls’
- 1981 Soft Rock Duet, Rumored to Be About Carly Simon and Linda Ronstadt, Is Still a Mystery 45 Years Later
- Could This Be the Next ‘Making a Murderer’? A Former Reality Star’s 92-Year Prison Sentence Is Getting New Attention